National Pension Service Lowers Holdings in Humana Inc. $HUM

National Pension Service reduced its position in shares of Humana Inc. (NYSE:HUM) by 9.1% during the 2nd quarter, HoldingsChannel reports. The firm owned 184,451 shares of the insurance provider’s stock after selling 18,452 shares during the period. National Pension Service’s holdings in Humana were worth $45,095,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the company. Cary Street Partners Investment Advisory LLC grew its position in shares of Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after buying an additional 46 shares in the last quarter. Zions Bancorporation National Association UT purchased a new stake in Humana in the first quarter worth about $37,000. CVA Family Office LLC grew its holdings in Humana by 63.4% during the 2nd quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock worth $54,000 after acquiring an additional 85 shares in the last quarter. Ransom Advisory Ltd bought a new position in Humana during the 1st quarter worth about $66,000. Finally, Transamerica Financial Advisors LLC increased its position in Humana by 1,027.6% during the 1st quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock valued at $87,000 after purchasing an additional 298 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

HUM has been the subject of several research reports. Piper Sandler lowered their price target on shares of Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research report on Thursday, July 31st. Truist Financial lowered their target price on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a report on Monday. The Goldman Sachs Group initiated coverage on Humana in a research report on Tuesday, October 14th. They set a “sell” rating and a $235.00 target price on the stock. Sanford C. Bernstein lifted their price target on Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a report on Friday, September 5th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $298.39.

Humana Stock Performance

Shares of HUM stock opened at $236.75 on Friday. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The business’s fifty day simple moving average is $272.46 and its 200-day simple moving average is $258.23. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a market cap of $28.47 billion, a PE ratio of 18.17, a PEG ratio of 1.71 and a beta of 0.42.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. During the same period in the previous year, the business earned $4.16 EPS. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. Analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.5%. Humana’s dividend payout ratio (DPR) is 33.18%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.